source
- Webinar explores how GLP-1 obesity drugs are reshaping US healthcare and market dynamicsThe upcoming webinar titled "The Massive Scale of GLP-1s: Evolving Health, Healthcare and Markets" will examine how GLP-1 receptor agonists used for obesity are altering the U.S. health-care landsc…
- Kura Oncology spins out diabetes program into new company with $50M funding and Lilly supportKura Oncology, known for its leukemia menin inhibitor Komzifti, announced it is separating its diabetes research into a newly formed company. The new entity will receive $50 million in financing,…